Abstract
Introduction
One major health care issue encountered in elderly cancer patients is the alteration of the quality of life. The purpose of our study is to evaluate the administration of chemotherapy in the last month of life (CLML) and to evaluate the impact of the palliative care consult (PCC) in the elderly patients.
Methods
We conducted a retrospective observational study that included elderly patients diagnosed with an end-stage cancer and who were deceased between the 1st of January 2012 and the 31st of December 2015. Patient medical records were reviewed for patients’ characteristics and management during the last month of life.
Results
This study enrolled 231 patients that fulfilled the eligibility criteria. CLML was administered in 91 patients (39.4 %) among which 43 patients (47.3 %) had their treatment within the last 2 weeks of life. Seventy-seven patients (33.3 %) had a palliative care consult (PCC) with a median duration of follow up of 13 days (range 2–56 days). Overall, PCC failed to decrease CLML administration, the duration of hospitalization, and ICU admissions. However, CLML administration decreased by 69 % among patients that had their PCC before receiving treatment (OR = 0.31; 95 % CI 0.15–0.63). PCC also led to a change in the pattern of treatment administered in the last month of life with less cytotoxic therapy (OR = 0.27 CI 95 % 0.09–0.9, p = 0.02) and higher rates of oral agents being prescribed (OR = 3.8; 95 % CI 1.3–11.3, p = 0.014).
Conclusion
Our elderly patients seem to receive aggressive management similar to the general oncology population. Early PCC was shown throughout our results to decrease the aggressiveness of cancer treatment in elderly patients which seems to improve the quality of care of our patients.
Similar content being viewed by others
References
Henderson TO, Ness KK, Cohen HJ (2014) Accelerated aging among cancer survivors: from pediatrics to geriatrics. Am Soc Clin Oncol Educ Book e423–430. doi:10.14694/EdBook_AM.2014.34.e423
Petrelli F, Borgonovo K, Cabiddu M, Lonati V, Barni S (2012) Mortality, leukemic risk, and cardiovascular toxicity of adjuvant anthracycline and taxane chemotherapy in breast cancer: a meta-analysis. Breast Cancer Res Treat 135(2):335–346
Moreh E, Jacobs JM, Stessman J (2010) Fatigue, function, and mortality in older adults. J Gerontol A Biol Sci Med Sci 65(8):887–895
Petera J, Dušek L (2013) Cancer in the elderly. Rep Pract Oncol Radiother 18(1):1–5
Shetty P (2012) Grey matter: ageing in developing countries. Lancet Lond Engl 379(9823):1285–1287
Assi T, Rassy EE, Tabchi S, Ibrahim T, Moussa T, Chebib R et al (2015) Treatment of cancer patients in their last month of life: aimless chemotherapy. Support Care Cancer 21:1–6
Abdulrahim S, Ajrouch KJ, Antonucci TC (2015) Aging in Lebanon: challenges and opportunities. The Gerontologist 55(4):511–518
Bruera E, Yennurajalingam S (2012) Palliative care in advanced cancer patients: how and when? Oncologist 17(2):267–273
Falandry C, Bonnefoy M, Freyer G, Gilson E (2014) Biology of cancer and aging: a complex association with cellular senescence. J Clin Oncol Off J Am Soc Clin Oncol 32(24):2604–2610
Extermann M (2010) Geriatric oncology: an overview of progresses and challenges. Cancer Res Treat Off J Korean Cancer Assoc 42(2):61–68
Hajjar RR, Atli T, Al-Mandhari Z, Oudrhiri M, Balducci L, Silbermann M (2013) Prevalence of aging population in the Middle East and its implications on cancer incidence and care. Ann Oncol Off J Eur Soc Med Oncol ESMO 24(Suppl 7):vii11-24
Sibai AM, Sen K, Baydoun M, Saxena P (2004) Population ageing in Lebanon: current status, future prospects and implications for policy. Bull World Health Organ 82(3):219–225
Boulos C, Salameh P, Barberger-Gateau P (2013) The AMEL study, a cross sectional population-based survey on aging and malnutrition in 1200 elderly Lebanese living in rural settings: protocol and sample characteristics. BMC Public Health 13:573
Yancik R, Carbone PP, Patterson WP (1983) Perspectives on prevention and treatment of cancer in the elderly. Raven Press, New York, pp 63–72
Walko CM, McLeod HL (2014) Personalizing medicine in geriatric oncology. J Clin Oncol Off J Am Soc Clin Oncol 32(24):2581–2586
Tabchi S, Rassy EE, Khazaka A, Karak FE, Kourie HR, Chebib R et al (2015) Validation of the EORTC QLQ-INFO 25 questionnaire in Lebanese cancer patients: is ignorance a bliss? Qual Life Res 10:1–8
Higginson IJ, Sen-Gupta GJ (2000) Place of care in advanced cancer: a qualitative systematic literature review of patient preferences. J Palliat Med 3(3):287–300
Gomes B, Calanzani N, Curiale V, McCrone P, Higginson IJ (2013) Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers. Cochrane Database Syst Rev 6:CD007760
Ringdal GI, Jordhøy MS, Kaasa S (2002) Family satisfaction with end-of-life care for cancer patients in a cluster randomized trial. J Pain Symptom Manag 24(1):53–63
Kinoshita H, Maeda I, Morita T, Miyashita M, Yamagishi A, Shirahige Y et al (2015) Place of death and the differences in patient quality of death and dying and caregiver burden. J Clin Oncol Off J Am Soc Clin Oncol 33(4):357–363
Currow DC, Burns CM, Abernethy AP (2008) Place of death for people with noncancer and cancer illness in South Australia: a population-based survey. J Palliat Care 24(3):144–150
Hong CY, Chow KY, Poulose J, Jin AZ, Devi A, Chee EMF et al (2011) Place of death and its determinants for patients with cancer in Singapore: an analysis of data from the Singapore cancer registry, 2000–2009. J Palliat Med 14(10):1128–1134
Office of National Statistics, Annual review of the registrar General on deaths in England and Wales, 2000. www.statistics.gov.uk/downloads/theme_heealth/DH1_33/Table17.xls. Accessed on 5 Mar 2013
Facts on dying (2004) http://www.chcr.brown.edu/dying/2001DATA.HTM. Accessed on 5 Mar 2013
Hajjar RR, Charalambous HA, Baider L, Silbermann M (2015) International palliative care: Middle East experience as a model for global palliative care. Clin Geriatr Med 31(2):281–294
Wright M, Wood J, Lynch T, Clark D (2008) Mapping levels of palliative care development: a global view. J Pain Symptom Manag 35(5):469–485
Ghosn M, Nassani N, Ghanem S, Ibrahim T (2015) Physical performance test and Karnofsky performance status are unable to identify elderly cancer patients requiring a comprehensive geriatric assessment. Eur Geriatr Med 6(5):427–432
Kim JW, Kim YJ, Lee K-W, Chang H, Lee J-O, Kim K-I et al (2014) The early discontinuation of palliative chemotherapy in older patients with cancer. Support Care Cancer Off J Multinatl Assoc Support Care Cancer. 22(3):773–781
Prigerson HG, Bao Y, Shah MA, Paulk ME, LeBlanc TW, Schneider BJ, et al (2015) Chemotherapy use, performance status, and quality of life at the end of life. JAMA Oncol
Mandelblatt JS, Jacobsen PB, Ahles T (2014) Cognitive effects of cancer systemic therapy: implications for the care of older patients and survivors. J Clin Oncol Off J Am Soc Clin Oncol 32(24):2617–2626
O’Brien MER, Borthwick A, Rigg A, Leary A, Assersohn L, Last K et al (2006) Mortality within 30 days of chemotherapy: a clinical governance benchmarking issue for oncology patients. Br J Cancer 95(12):1632–1636
Wright AA, Zhang B, Keating NL, Weeks JC, Prigerson HG (2014) Associations between palliative chemotherapy and adult cancer patients’ end of life care and place of death: prospective cohort study. BMJ 348:g1219
Naeim A, Aapro M, Subbarao R, Balducci L (2014) Supportive care considerations for older adults with cancer. J Clin Oncol Off J Am Soc Clin Oncol 32(24):2627–2634
Kelley AS, Meier DE (2010) Palliative care—a shifting paradigm. N Engl J Med 363(8):781–782
Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA et al (2010) Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med 363(8):733–742
Dionne-Odom JN, Azuero A, Lyons KD, Hull JG, Tosteson T, Li Z, et al. (2015) Benefits of early versus delayed palliative care to informal family caregivers of patients with advanced cancer: outcomes from the enable iii randomized controlled trial. J Clin Oncol. JCO.2014.58.7824.
Meier DE, Brawley OW (2011) Palliative care and the quality of life. J Clin Oncol Off J Am Soc Clin Oncol 29(20):2750–2752
Wright AA, Hatfield LA, Earle CC, Keating NL (2014) End-of-life care for older patients with ovarian cancer is intensive despite high rates of hospice use. J Clin Oncol Off J Am Soc Clin Oncol 32(31):3534–3539
Roeland EJ, Triplett DP, Matsuno RK, Boero IJ, Hwang L, Yeung HN et al (2016) Patterns of palliative care consultation among elderly patients with cancer. J Natl Compr Cancer Netw JNCCN 14(4):439–445
Harrington SE, Smith TJ (2008) The role of chemotherapy at the end of life: “when is enough, enough?”. JAMA 299(22):2667–2678
Cheng H-WB, Li C-W, Chan K-Y, Au H-Y, Chan P-F, Sin Y-C et al (2015) End-of-life characteristics and palliative care provision for elderly patients suffering from acute myeloid leukemia. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 23(1):111–116
Breuer B, Fleishman SB, Cruciani RA, Portenoy RK (2011) Medical oncologists’ attitudes and practice in cancer pain management: a national survey. J Clin Oncol Off J Am Soc Clin Oncol 29(36):4769–4775
Acknowledgments
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Funding
This study received no funding.
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Assi, T., El Rassy, E., Ibrahim, T. et al. The role of palliative care in the last month of life in elderly cancer patients. Support Care Cancer 25, 599–605 (2017). https://doi.org/10.1007/s00520-016-3444-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-016-3444-3